Stock

CTOR

CITIUS ONCOLOGY, INC.

Latest close $0.830 of 27 marquee funds currently hold1 CUSIP mapped

Current holders

27 funds tracked

Ever held

Current + past

New this quarter

Exited this quarter

Marquee-fund ownership over time

Feb 13, 2025May 15, 2025Feb 12, 2026May 15, 2026

Now

This quarter's activity

New positions opened

None.

Positions exited

Two Sigma Investments
Q2 2026 · -18%
EXIT

Past holders

Funds that exited at some point

Fund	Last entry	Exited	Entry → Exit	Return
Two Sigma Investments	Q1 2026	Q2 2026	→ $0.96	-18%
Citadel Advisors 2× in & out	Q4 2025	Q1 2026	→ $1.18	-6%
Renaissance Technologies 2× in & out	Q4 2025	Q1 2026	→ $1.18	-11%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at CITIUS ONCOLOGY, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d

Filings · last 90d

Total on file

Recent SEC buffer

Most recent

Dec 22, 2025

30d / 90d windows measured from Dec 22, 2025 — the most recent Form 4 on file — not from today.

Showing 15 of 54 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · CITIUS ONCOLOGY, INC.

Annual figures sourced directly from CITIUS ONCOLOGY, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Net income

-$24.76M

FY2025-17% YoY

EPS (basic)

$-0.3400

FY2025-10% YoY

Free cash flow(?)

-$5.49M

FY2025-500%+ YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for CITIUS ONCOLOGY, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds

Fund	Open date	Close date	Open price	Close price / current	Return
Two Sigma Investments	Q1 2026	Q2 2026	$1.18	$0.96	-18%
Citadel Advisors	Q4 2025	Q1 2026	$1.25	$1.18	-6%
Renaissance Technologies	Q4 2025	Q1 2026	$1.33	$1.18	-11%
Citadel Advisors	Q1 2025	Q2 2025	$1.25	$0.88	-29%
Renaissance Technologies	Q1 2025	Q2 2025	$1.28	$0.89	-30%

Caveats

Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
“Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.